Ardsley Advisory Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-61,000
Closed -$8.05M 166
2024
Q1
$8.05M Buy
+61,000
New +$7.52M 1.16% 25
2020
Q4
Sell
-8,908
Closed -$704K 176
2020
Q3
$704K Buy
8,908
+4,716
+113% +$369K 0.14% 85
2020
Q2
$309K Sell
4,192
-1,205
-22% -$90.7K 0.07% 102
2020
Q1
$397K Buy
+5,397
New +$424K 0.16% 69
2019
Q4
Sell
-6,812
Closed -$547K 177
2019
Q3
$547K Sell
6,812
-524
-7% -$42K 0.12% 89
2019
Q2
$587K Buy
+7,336
New +$562K 0.09% 86
2019
Q1
Sell
-6,288
Closed -$458K 143
2018
Q4
$458K Sell
6,288
-1,572
-20% -$111K 0.12% 68
2018
Q3
$532K Sell
7,860
-102,180
-93% -$6.51M 0.07% 102
2018
Q2
$6.37M Buy
110,040
+105,324
+2,233% +$5.94M 0.96% 41
2018
Q1
$245K Buy
+4,716
New +$255K 0.04% 133
2017
Q4
Sell
-5,240
Closed -$320K 164
2017
Q3
$320K Buy
+5,240
New +$318K 0.04% 109
2017
Q1
Sell
-7,860
Closed -$442K 175
2016
Q4
$442K Buy
+7,860
New +$460K 0.07% 92
2015
Q3
Sell
-8,384
Closed -$462K 170
2015
Q2
$462K Sell
8,384
-3,144
-27% -$176K 0.06% 113
2015
Q1
$632K Hold
11,528
0.09% 112
2014
Q4
$625K Buy
11,528
+1,048
+10% +$58.4K 0.1% 105
2014
Q3
$593K Buy
10,480
+2,620
+33% +$147K 0.08% 103
2014
Q2
$434K Hold
7,860
0.06% 170
2014
Q1
$426K Buy
7,860
+2,620
+50% +$136K 0.06% 148
2013
Q4
$250K Hold
5,240
0.03% 134
2013
Q3
$238K Sell
5,240
-1,048
-17% -$47.8K 0.05% 112
2013
Q2
$279K Buy
+6,288
New +$281K 0.06% 103

Other funds holding MRK

Ardsley Advisory Partners's MRK Position: Q2 2024 in Review

Ardsley Advisory Partners sold out of Merck (MRK) in Q2 2024, closing a stake of 61,000 shares — an estimated $8.05M sold.

Ardsley Advisory Partners first reported a position in MRK in Q2 2013 and held it in 21 quarters. The position peaked at $8.05M in Q1 2024. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Ardsley Advisory Partners reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Ardsley Advisory Partners sold 61,000 Merck shares in Q2 2024, an estimated $8.05M.
  • Ardsley Advisory Partners first reported a position in Merck in Q2 2013 and held it in 21 quarters.
  • Ardsley Advisory Partners's Merck position peaked at $8.05M in Q1 2024.
  • 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Ardsley Advisory Partners's 13F filing for Q2 2024, filed 14 Aug 2024.